← Back to Search

Empowerment-Based Tobacco Cessation Assistance for Smoking Cessation

N/A
Recruiting
Led By Julia McQuoid, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 month of data collection completion
Awards & highlights

Study Summary

This trial will assess an empowerment approach to help SGM adults quit smoking, the leading cause of preventable death. It will link individual well-being with larger social and political contexts to promote positive behavior change.

Who is the study for?
This trial is for LGBTQ+ adults in Oklahoma who smoke, want to quit, and are willing to engage in community empowerment activities. Participants must be over 18, speak English, plan to stop smoking within two weeks, and not use any substances that could affect breath tests. Those with conditions conflicting with nicotine replacement therapy cannot join.Check my eligibility
What is being tested?
The study is testing a tobacco cessation program enhanced by empowerment activities aimed at the LGBTQ+ community. It combines standard quitting support with involvement in SGM organizing tasks. The impact of this approach on participants' ability to quit smoking will be evaluated through surveys and interviews.See study design
What are the potential side effects?
Since the intervention focuses on behavioral support rather than medication (except standard nicotine replacement), side effects may include stress or discomfort related to quitting smoking or participating in empowerment activities.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 month of data collection completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 month of data collection completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
biochemical verification of tobacco abstinence
change in adaptive coping strategies
community partner perceptions of the intervention
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Empowerment activity-enhanced tobacco cessation assistanceExperimental Treatment1 Intervention
Single arm pilot intervention design to assess feasibility and acceptability

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
98,101 Total Patients Enrolled
Julia McQuoid, PhDPrincipal InvestigatorUniversity of Oklahoma

Media Library

Empowerment activity-enhanced tobacco cessation assistance Clinical Trial Eligibility Overview. Trial Name: NCT05365633 — N/A
Smoking Cessation Research Study Groups: Empowerment activity-enhanced tobacco cessation assistance
Smoking Cessation Clinical Trial 2023: Empowerment activity-enhanced tobacco cessation assistance Highlights & Side Effects. Trial Name: NCT05365633 — N/A
Empowerment activity-enhanced tobacco cessation assistance 2023 Treatment Timeline for Medical Study. Trial Name: NCT05365633 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals eligible to enroll in this experiment currently?

"Affirmative. According to the information available on clinicaltrials.gov, this medical trial is actively seeking participants for its study. The inaugural post was made June 1st 2022 and the listing has been revised as recently as March 2nd 2023. A total of 20 subjects are being recruited from a single site."

Answered by AI

What is the current participation rate for this research project?

"Affirmative. According to information listed on clinicaltrials.gov, the research project was announced on June 1st 2022 and has been actively searching for participants since then with a most recent update being March 2nd 2023. The trial is currently seeking out 20 individuals at one location."

Answered by AI
~0 spots leftby Apr 2024